These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11306785)

  • 1. Improvement of water-soluble cephalosporin derivatives having antibacterial activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Nomura S; Akagi H; Hiramatsu K
    Chemotherapy; 2001; 47(3):170-6. PubMed ID: 11306785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Masaru Y; Otani T; Hyodo A; Hiramatsu K
    Antimicrob Agents Chemother; 1995 May; 39(5):1120-6. PubMed ID: 7625799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MRSA cephems. Part 3: additional C-7 acid derivatives.
    Springer DM; Luh BY; Goodrich JT; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):281-91. PubMed ID: 12470721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives.
    Springer DM; Luh BY; Goodrich J; Bronson JJ
    Bioorg Med Chem; 2003 Jan; 11(2):265-79. PubMed ID: 12470720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on anti-MRSA parenteral cephalosporins. IV. A novel water-soluble N-phosphono type prodrug for parental administration.
    Ishikawa T; Nakayama Y; Tomimoto M; Niwa SI; Kamiyama K; Hashiguchi S; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Apr; 54(4):364-74. PubMed ID: 11426661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
    J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cephalosporin derivatives possessing a substituted cinnamoyl moiety at the 7 beta-position. Synthesis, structural characterization and antibacterial activity of 3-acetoxymethyl cephalosporin derivatives.
    López MA; Rodríguez Z; González M; Tolón B; Avila R; González I; Garmendía L; Mamposo T; Carrasco R; Pellón R; Vélez H; Fini A
    Eur J Med Chem; 2004 Aug; 39(8):657-64. PubMed ID: 15276299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
    Glinka TW; Cho A; Zhang ZJ; Ludwikow M; Griffith D; Huie K; Hecker SJ; Dudley MN; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1045-52. PubMed ID: 11132949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
    Vouillamoz J; Entenza JM; Hohl P; Moreillon P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cephalosporins for the treatment of MRSA infections.
    Glinka TW
    Curr Opin Investig Drugs; 2002 Feb; 3(2):206-17. PubMed ID: 12020048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.